🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Blood Disease

A Study to Evaluate Performance, Usability, and Contrived Result Interpretation of TruPlex HIV/HepB/Syphilis Rapid Test NCT07563309NA3 sites📍 Johannesburg📍 Durban📍 Cape Town bioLytical Laboratories · Tests: TruPlex HIV/HepB/Syphilis Rapid Test Registry of the German CLL Study Group NCT02863692n/a1 site📍 Dresden German CLL Study Group ELVN-001 for the Treatment of Chronic Myeloid Leukemia With and Without T315I Mutation in Japanese Participants NCT06787144Phase 14 sites📍 Akita📍 Sapporo📍 Suita-shi Enliven Therapeutics · Tests: ELVN-001 ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV NCT06274632NA2 sites📍 Miami📍 Houston Massachusetts General Hospital · Tests: ADELANTE Study of Glecaprevir/Pibrentasvir to Assess Safety Through Real-World Data NCT07419347n/a2 sites📍 Vancouver📍 Toronto AbbVie Key Longitudinal Associations With Risk and Glioblastoma Outcomes NCT06625684n/a1 site📍 Durham Duke University A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency NCT07347249Phase 21 site📍 London Hemab ApS · Tests: Sutacimig, Sutacimig MitoQ and Ischemic Conditioning To Assess Vascular Health Outcomes NCT06930638Phase 21 site📍 Milwaukee Medical College of Wisconsin · Tests: Ischemic Conditioning, Antioxidant Supplement Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery NCT07362992EARLY Phase 14 sites📍 Holon📍 Kfar Saba📍 Petah Tikva Wolfson Medical Center · Tests: Tranexamic Acid (Topical), Normal Saline (Placebo) Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents NCT05442216Phase 27 sites📍 Miami📍 Orlando📍 Buffalo Joshua Zeidner · Tests: Tagraxofusp, Azacitidine, Venetoclax Biannual Review of Exhaled Air and Trends in Health Evaluation in COPD NCT07045948NA1 site📍 Jette Universitair Ziekenhuis Brussel · Tests: Blood eosinophil Count Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals NCT02472028Phase 42 sites📍 Bordeaux📍 Paris Assistance Publique - Hôpitaux de Paris · Tests: blood pressure lowering algorithm, usual strategy Sickle-cell Disease Registry of the GPOH NCT03327428n/a1 site📍 Heidelberg University Hospital Heidelberg Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients NCT07313592n/a1 site📍 St Louis Washington University School of Medicine Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant NCT03921047n/a1 site📍 Los Angeles University of Southern California · Tests: Biospecimen Collection, Laboratory Biomarker Analysis The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States Study NCT06854458NA13 sites📍 San Francisco📍 Louisville📍 Boston Brigham and Women's Hospital · Tests: Quantitative Myocardial Blood Flow Evaluation, Qualitative Myocardial Blood Flow Evaluation, Gadavist, Vasodilator, Blo… Effect of ANKASCIN 568-P Products Regulating Blood Lipid NCT05737355NA1 site📍 Taipei SunWay Biotech Co., LTD. · Tests: ANKASCIN 568-P Red yeast rice capsules, Placebo Capsules A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites📍 Phoenix📍 La Jolla📍 Los Angeles Kura Oncology, Inc. · Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma NCT07284758Phase 260 sites📍 Huntsville📍 Phoenix📍 Scottsdale C4 Therapeutics, Inc. · Tests: Cemsidomide, Dexamethasone An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A NCT07088458n/a12 sites📍 Loma Linda📍 New Brunswick📍 Many Locations Bayer · Tests: Damoctocog alfa pegol (Jivi, Bay94-9027) Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs NCT06111638Phase 2, Phase 310 sites📍 Beijing📍 Guangzhou📍 Guiyang Shanghai Xinzhi BioMed Co., Ltd. · Tests: Single dose intravenous injection of BBM-H803 Effect of Fish Oil on Hyperlipidemia and Toxicities in Children and Young Adults With Acute Lymphoblastic Leukemia NCT04209244NA4 sites📍 Aalborg📍 Aarhus📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: Eskimo-3 Pure Fish Oil, Rapeseed Oil A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma NCT07309614Phase 35 sites📍 Nedlands📍 Montreal📍 Québec Université de Sherbrooke · Tests: Dupilumab Prefilled Syringe, Placebo Injection Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B NCT06680232Phase 17 sites📍 Boston📍 Clichy📍 Hong Kong Precision BioSciences, Inc. · Tests: PBGENE-HBV Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance NCT06483100Phase 21 site📍 St Louis Washington University School of Medicine · Tests: Elrantamab, clonoSEQ Molecular Characteristics of Hepatitis B Virus Integration, Mutation, and Drug Resistance NCT06779864n/a1 site📍 Beijing Beijing Friendship Hospital Peking University Birth Cohort in Weifang (PKUBC-WF) NCT06234332n/a1 site📍 Beijing Peking University · Tests: No Interventions TGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic Malignancies NCT06484816Phase 11 site📍 Hangzhou Shenzhen TargetRx Co., Ltd. · Tests: TGRX-1942 Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma NCT05896228Phase 21 site📍 Miami Benjamin T Diamond, MD · Tests: Iberdomide, Carfilzomib, Daratumumab, Dexamethasone, Acetaminophen A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma NCT05645107Phase 362 sites📍 Bullhead City📍 Huntington Park📍 St. Petersburg Grifols Therapeutics LLC · Tests: Xembify, Placebo
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy